Holen Sie sich die Stockscreener-App
0.4199
7.31%
-0.0331
Handel nachbörslich:
.42
0.000100
+0.02%
Schlusskurs vom Vortag:
$0.453
Offen:
$0.45
24-Stunden-Volumen:
181.77K
Relative Volume:
0.69
Marktkapitalisierung:
$14.46M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-7.60M
KGV:
-1.8465
EPS:
-0.2274
Netto-Cashflow:
$-6.74M
1W Leistung:
-25.98%
1M Leistung:
-31.80%
6M Leistung:
-65.86%
1J Leistung:
-34.60%
1-Tages-Spanne:
$0.3875
$0.4998
1-Wochen-Bereich:
$0.3875
$0.56
52-Wochen-Spanne:
$0.3875
$3.33
Jupiter Neurosciences Inc Stock (JUNS) Company Profile
Firmenname
Jupiter Neurosciences Inc
Sektor
Branche
Telefon
(561) 406-6154
Adresse
1001 NORTH US HWY 1, JUPITER
Compare JUNS vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
JUNS
Jupiter Neurosciences Inc
|
0.4199 | 15.60M | 0 | -7.60M | -6.74M | -0.2274 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.11 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Jupiter Neurosciences Inc Aktie (JUNS) Neueste Nachrichten
Aug Rallies: Can Jupiter Neurosciences Inc scale operations efficientlyJuly 2025 Selloffs & Expert Curated Trade Setup Alerts - baoquankhu1.vn
JUNS Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Jupiter Neurosciences to Present at BIO Investment and Growth Summit 2026 - mydailyrecord.com
JUNS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Jupiter Neurosciences Receives Nasdaq Deficiency Notices, Faces Delisting - TipRanks
Jupiter Neurosciences Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Jupiter Neurosciences (JUNS) faces Nasdaq bid price and $35M value shortfall - Stock Titan
JUNS Should I Buy - Intellectia AI
Jupiter Neurosciences Invited to Present Clinical and Commercial Progress at Investor Dinner at Mar-a-Lago - BioSpace
Inside Jupiter Neurosciences’ Mar-a-Lago talk on Parkinson’s and Nugevia - Stock Titan
Chipmakers Recap: Does Sun Life Financial Inc stock have upside surprise potentialWeekly Trade Analysis & Consistent Return Strategy Ideas - baoquankhu1.vn
Jupiter Neurosciences Amends Yorkville Installment Provisions to Align Capital With Clinical and Commercial Execution - Delawareonline.com
Aug PostEarnings: How sensitive is HSTM to inflationTrade Volume Summary & Low Drawdown Investment Strategies - baoquankhu1.vn
Jupiter Neurosciences Amends Yorkville Financing Agreement Terms - TipRanks
Can Jupiter Neurosciences Inc. stock attract ESG capital inflowsMarket Rally & AI Forecasted Entry and Exit Points - mfd.ru
What is the earnings history of Jupiter Neurosciences Inc.Trade Entry Report & Weekly Watchlist for Consistent Profits - mfd.ru
Jupiter Neuroscience and ANNIKA Women’s All Pro Tour Announce Multi-Year Partnership - The Golf Wire
Can Jupiter Neurosciences Inc reach resistance levels soon2025 Dividend Review & Low Risk High Win Rate Picks - baoquankhu1.vn
Big Picture: What is the next catalyst for Jupiter Neurosciences Inc.July 2025 Drop Watch & Reliable Breakout Stock Forecasts - mfd.ru
Aug Wrap: Can Jupiter Neurosciences Inc. stock attract ESG capital inflowsInsider Selling & Long-Term Growth Plans - mfd.ru
Analyst Upgrade: Should I average down on PTPI stock2025 Trade Ideas & AI Forecasted Entry and Exit Points - baoquankhu1.vn
Jupiter Neurosciences Selected as B2i Digital Featured Company - The Progress Index
Can Jupiter Neurosciences Inc. reach all time highs this year2025 Retail Activity & Growth Oriented Trading Recommendations - mfd.ru
Jupiter Neurosciences Selected as B2i Digital Featured Company Amid Parkinson's Trial and Consumer Brand Expansion - citybuzz -
Signal Recap: What analysts say about Jupiter Neurosciences Inc stockWeekly Investment Recap & Low Risk Profit Maximizing Plans - baoquankhu1.vn
Jupiter Neurosciences Selected as B2i Digital Featured Company | Corporate - EQS News
Will Jupiter Neurosciences Inc. stock attract more institutional investors2025 Risk Factors & High Accuracy Swing Trade Signals - mfd.ru
Travel Stocks: Is Jupiter Neurosciences Inc currently under institutional pressureTrade Entry Report & AI Powered Market Entry Ideas - baoquankhu1.vn
Aug Analyst Calls: Is Jupiter Neurosciences Inc in a long term uptrendJuly 2025 Retail & Trade Opportunity Analysis Reports - baoquankhu1.vn
Dow Update: Will Cineverse Corp outperform tech stocksM&A Rumor & Weekly High Return Stock Forecasts - baoquankhu1.vn
Jupiter Neurosciences Expands Nugevia™ Addressable Market with Focus on GLP-1 Users - The Desert Sun
Aug Reactions: Will Whitehawk Therapeutics Inc outperform tech stocks2025 Price Action Summary & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Gains Recap: Does Verde Clean Fuels Inc. have strong EBITDA marginsMarket Weekly Review & AI Forecasted Stock Moves - baoquankhu1.vn
Jupiter Neurosciences launches support initiative for GLP-1 users By Investing.com - Investing.com Nigeria
Jupiter Neurosciences Expands Nugevia™ Addressable Market With Focus On GLP-1 Users - Tampa Free Press
Portfolio Recap: What analysts say about ALCY stockCPI Data & Community Verified Watchlist Alerts - baoquankhu1.vn
Jupiter Neurosciences Expands Nugevia Addressable Market with Focus on GLP-1 Users - marketscreener.com
Jupiter Neurosciences launches support initiative for GLP-1 users - Investing.com
Jupiter Neurosciences expands Nugevia addressable market with focus on GLP-1 users - marketscreener.com
Jupiter Launches Nugevia™ to Support GLP-1 Weight Loss - Intellectia AI
Jupiter Neurosciences Presenting at the 3rd Annual DealFlow Discovery Conference - morningsun.net
Jupiter Neurosciences To Showcase Lead Program JOTROL At The DealFlow Discovery Conference - Nasdaq
CEO of Jupiter Neurosciences to meet investors at Atlantic City conference - Stock Titan
Income Plays: Can Jupiter Neurosciences Inc reach all time highs this yearJuly 2025 Intraday Action & Weekly Setup with ROI Potential - baoquankhu1.vn
Chart Watch: What’s Greenpro Capital Corp.’s historical returnJuly 2025 Selloffs & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
US Market Recap: What is the earnings history of Jupiter Neurosciences Inc2025 Stock Rankings & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Finanzdaten der Jupiter Neurosciences Inc-Aktie (JUNS)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.69%
0.68%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):